These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27856406)

  • 1. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.
    Smit MR; Ochomo E; Aljayyoussi G; Kwambai T; Abong'o B; Bayoh N; Gimnig J; Samuels A; Desai M; Phillips-Howard PA; Kariuki S; Wang D; Ward S; Ter Kuile FO
    JMIR Res Protoc; 2016 Nov; 5(4):e213. PubMed ID: 27856406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Chen T; Bousema T; Slater HC; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Lancet Infect Dis; 2018 Jun; 18(6):615-626. PubMed ID: 29602751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial).
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Bousema T; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Clin Infect Dis; 2019 Sep; 69(7):1112-1119. PubMed ID: 30590537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
    Smit MR; Ochomo EO; Waterhouse D; Kwambai TK; Abong'o BO; Bousema T; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ter Kuile FO; Ward SA; Aljayyoussi G
    Clin Pharmacol Ther; 2019 Feb; 105(2):388-401. PubMed ID: 30125353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.
    Foy BD; Some A; Magalhaes T; Gray L; Rao S; Sougue E; Jackson CL; Kittelson J; Slater HC; Bousema T; Da O; Coulidiaty AGV; Colt M; Wade M; Richards K; Some AF; Dabire RK; Parikh S
    JMIR Res Protoc; 2023 Mar; 12():e41197. PubMed ID: 36939832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
    Dabira ED; Soumare HM; Conteh B; Ceesay F; Ndiath MO; Bradley J; Mohammed N; Kandeh B; Smit MR; Slater H; Peeters Grietens K; Broekhuizen H; Bousema T; Drakeley C; Lindsay SW; Achan J; D'Alessandro U
    Lancet Infect Dis; 2022 Apr; 22(4):519-528. PubMed ID: 34919831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.
    Chaccour C; Casellas A; Hammann F; Ruiz-Castillo P; Nicolas P; Montaña J; Mael M; Selvaraj P; Duthaler U; Mrema S; Kakolwa M; Lyimo I; Okumu F; Marathe A; Schürch R; Elobolobo E; Sacoor C; Saute F; Xia K; Jones C; Rist C; Maia M; Rabinovich NR
    Trials; 2023 Feb; 24(1):128. PubMed ID: 36810194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi.
    Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Durand S; Smith ES; Baldeviano GC; Gerbasi RV; Ballard SB; Stoops CA; Vásquez GM
    Malar J; 2017 Nov; 16(1):474. PubMed ID: 29162101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
    Slater HC; Foy BD; Kobylinski K; Chaccour C; Watson OJ; Hellewell J; Aljayyoussi G; Bousema T; Burrows J; D'Alessandro U; Alout H; Ter Kuile FO; Walker PGT; Ghani AC; Smit MR
    Lancet Infect Dis; 2020 Apr; 20(4):498-508. PubMed ID: 31948767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.
    Kobylinski KC; Ubalee R; Ponlawat A; Nitatsukprasert C; Phasomkulsolsil S; Wattanakul T; Tarning J; Na-Bangchang K; McCardle PW; Davidson SA; Richardson JH
    Malar J; 2017 Jul; 16(1):280. PubMed ID: 28687086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal and sublethal impacts of membrane-fed ivermectin are concentration dependent in Anopheles coluzzii.
    Shepherd-Gorringe MAM; Pettit MW; Hawkes FM
    Parasit Vectors; 2024 May; 17(1):228. PubMed ID: 38755640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a cluster randomised placebo-controlled trial of adjunctive ivermectin mass drug administration for malaria control on the Bijagós Archipelago of Guinea-Bissau: the MATAMAL trial.
    Hutchins H; Bradley J; Pretorius E; Teixeira da Silva E; Vasileva H; Jones RT; Ndiath MO; Dit Massire Soumare H; Mabey D; Nante EJ; Martins C; Logan JG; Slater H; Drakeley C; D'Alessandro U; Rodrigues A; Last AR
    BMJ Open; 2023 Jul; 13(7):e072347. PubMed ID: 37419638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors.
    Ominde KM; Kamau Y; Karisa J; Muturi MN; Kiuru C; Wanjiku C; Babu L; Yaah F; Tuwei M; Musani H; Ondieki Z; Muriu S; Mwangangi J; Chaccour C; Maia MF
    Malar J; 2023 Sep; 22(1):291. PubMed ID: 37777725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial.
    Dabira ED; Soumare HM; Lindsay SW; Conteh B; Ceesay F; Bradley J; Kositz C; Broekhuizen H; Kandeh B; Fehr AE; Nieto-Sanchez C; Ribera JM; Peeters Grietens K; Smit MR; Drakeley C; Bousema T; Achan J; D'Alessandro U
    JMIR Res Protoc; 2020 Nov; 9(11):e20904. PubMed ID: 33211022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial.
    Ekoka Mbassi D; Mombo-Ngoma G; Held J; Okwu DG; Ndzebe-Ndoumba W; Kalkman LC; Ekoka Mbassi FA; Pessanha de Carvalho L; Inoue J; Akinosho MA; Dimessa Mbadinga LB; Yovo EK; Mordmüller B; Kremsner PG; Adegnika AA; Ramharter M; Zoleko-Manego R
    EBioMedicine; 2023 Nov; 97():104814. PubMed ID: 37839134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors.
    Sylla M; Kobylinski KC; Gray M; Chapman PL; Sarr MD; Rasgon JL; Foy BD
    Malar J; 2010 Dec; 9():365. PubMed ID: 21171970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety.
    Chaccour C; Hammann F; Rabinovich NR
    Malar J; 2017 Apr; 16(1):161. PubMed ID: 28434401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What does not kill it makes it weaker: effects of sub-lethal concentrations of ivermectin on the locomotor activity of Anopheles aquasalis.
    Sampaio VS; Rivas GBDS; Kobylinski K; Pinilla YT; Pimenta PFP; Lima JBP; Bruno RV; Lacerda MVG; Monteiro WM
    Parasit Vectors; 2017 Dec; 10(1):623. PubMed ID: 29282130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pigs with endectocides as a complementary tool for combating malaria transmission by Anopheles farauti (s.s.) in Papua New Guinea.
    Pasay CJ; Yakob L; Meredith HR; Stewart R; Mills PC; Dekkers MH; Ong O; Llewellyn S; Hugo RLE; McCarthy JS; Devine GJ
    Parasit Vectors; 2019 Mar; 12(1):124. PubMed ID: 30890165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.